← GODS Home
⌬
❀
❀
❀
❀
❀
⌬
❀
❀
❀
⌬
❀
❀
❀
❀
⌬
❀
❀
⌬
❀
❀
⌬
❀
❀
❀
⌬
❀
⌬
❀
⌬
❀
❀
♧
Elk Velvet Antler
Ingredient · 9 compounds · 7 conditions
Elk Velvet Antler is profiled across the CytoSolve® knowledge base and mapped to the disease biology it influences — tracing each of its compounds through disease, biological process, molecular pathway and down to individual biomarkers, with source videos and references at each step.
Compounds in this ingredient
⌬Arachidonic acid⌬Eucalyptol⌬Leucine⌬Magnesium⌬Oleic acid⌬Palmitic acid⌬Palmitoleic Acid⌬Stearic acid⌬α-Linolenic acid
Conditions addressed
❀Liver Health❀Men's Health❀Muscle Gain❀Neurodegenerative Diseases❀Osteoarthritis❀Rheumatoid Arthritis❀Viral Infections
Compare
Add ingredients to compare side-by-side
Comparison
Ingredient → Compounds → Diseases → Biological Processes → Molecular Pathways → Biomarkers
All
Compound
Disease
Biological Process
Molecular Pathway
⌬Compound · 5 disease(s) · 5 pathway(s)▸
Compound · 5 disease(s) · 5 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ NF-κB Signaling
◈ TargetNF-κB
◆IL-6 and TNF-α
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ LPS/TLR Signaling
◈ TargetTNF-α
◆TNF-α
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Muscle Hypertrophy1 pathway
▸▣ AKT/mTOR Signaling
◈ TargetP-AKT
◆PKC, Rac1
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Sexual Dysfunction1 pathway
▸▣ Ca2+ Signaling
◈ TargetCa2+ Influx
◆BCL-xS, BCL-xL
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Osteoclastogenesis1 pathway
▸▣ RANK/RANKL Signaling
◈ TargetOsteoprotegerin
◆Osteoprotegerin
⌬Compound · 3 disease(s) · 3 pathway(s)▸
Compound · 3 disease(s) · 3 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Apoptosis1 pathway
▸▣ ROS/Caspase-3 Signaling
◈ TargetROS
◆BCL-2, BAX, Caspase-3
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ LPS/TLR Signaling
◈ TargetNF-κB
◆IL‐1β, NO
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Oxidative Stress1 pathway
▸▣ Nrf2/Keap1 Signaling
◈ TargetNrf2
◆ROS, HO-1, SOD, CAT
⌬Compound · 4 disease(s) · 5 pathway(s)▸
Compound · 4 disease(s) · 5 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Neurodegeneration1 pathway
▸▣ Nrf2/HO/JNK Signaling
◈ TargetJNK
◆HO-1, BAX, IL-1β
❀Disease · 2 process(es) · 2 pathway(s)▸
Disease · 2 process(es) · 2 pathway(s)
▸✣ Inflammation1 pathway
▸▣ Arachidonic Acid Signaling
◈ TargetCOX-2
◆COX-2, TNF-α, PGE-2
▸✣ Bone Degeneration1 pathway
▸▣ NF-κB Signaling
◈ TargetNF-κB
◆iNOS, COX-2, IL-6, IL-β
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ RANKL/JNK Signaling
◈ TargetP-JNK
◆IL-6 and TNF-α
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ NF-κB Signaling
◈ TargetNF-κB
◆iNOS, COX-2, TNF-α
⌬Compound · 2 disease(s) · 2 pathway(s)▸
Compound · 2 disease(s) · 2 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ TNF-α Signaling
◈ TargetNF-κB
◆IL-6, TNF-α
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Muscle Hypertrophy1 pathway
▸▣ mTOR Signaling
◈ TargetATP
◆S6K, 4EBP1
⌬Compound · 2 disease(s) · 2 pathway(s)▸
Compound · 2 disease(s) · 2 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Cartilage Degeneration1 pathway
▸▣ TLR4/NF-κB Signaling
◈ TargetMMP-1
◆MMP-1
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Sexual Dysfunction1 pathway
▸▣ Ca2+ Signaling
◈ TargetCa2+ Influx
◆Ca2+ Level
⌬Compound · 3 disease(s) · 3 pathway(s)▸
Compound · 3 disease(s) · 3 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ NLRP3 Signaling
◈ TargetNLRP3
◆MCP-1, iNOS, TNF-α, IL-6, COX-2
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Hormonal Imbalance1 pathway
▸▣ ERK Signaling
◈ TargetGPCR
◆Testosterone
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ LPS/TLR4 Signaling
◈ TargetMD2
◆IL-6, TNF-α
⌬Compound · 1 disease(s) · 1 pathway(s)▸
Compound · 1 disease(s) · 1 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ BDL/NF-κB Signaling
◈ TargetNF-κB
◆IL-10, IL-6, TNF-α
⌬Compound · 1 disease(s) · 1 pathway(s)▸
Compound · 1 disease(s) · 1 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Muscle Hypertrophy1 pathway
▸▣ mTOR Signaling
◈ TargetmTOR
◆S6K, 4EBP2
⌬Compound · 2 disease(s) · 2 pathway(s)▸
Compound · 2 disease(s) · 2 pathway(s)
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Osteoclastogenesis1 pathway
▸▣ NF-κB Signaling
◈ TargetNF-κB
◆NFATc1, TRAP, MMP-9, CTSK
❀Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ NF-κB Signaling
◈ TargetPPARα
◆IL-1β, TNF-α, IL-6.